scholarly journals Long-term outcomes of patients with intraductal growth sub-type of intrahepatic cholangiocarcinoma

HPB ◽  
2018 ◽  
Vol 20 (12) ◽  
pp. 1189-1197 ◽  
Author(s):  
Fabio Bagante ◽  
Matthew Weiss ◽  
Sorin Alexandrescu ◽  
Hugo P. Marques ◽  
Luca Aldrighetti ◽  
...  
HPB ◽  
2018 ◽  
Vol 20 ◽  
pp. S5
Author(s):  
Ozgür Akgül ◽  
Fabio Bagante ◽  
Matthew Weiss ◽  
Katiuscha Merath ◽  
Sorin Alexandrescu ◽  
...  

HPB ◽  
2018 ◽  
Vol 20 ◽  
pp. S200
Author(s):  
F. Bagante ◽  
M. Weiss ◽  
S. Alexandrescu ◽  
H. Marques ◽  
L. Aldrighetti ◽  
...  

2018 ◽  
Vol 226 (4) ◽  
pp. 393-403 ◽  
Author(s):  
Kazunari Sasaki ◽  
Georgios A. Margonis ◽  
Nikolaos Andreatos ◽  
Fabio Bagante ◽  
Matthew Weiss ◽  
...  

2017 ◽  
Vol 35 (4_suppl) ◽  
pp. 275-275
Author(s):  
Bradley Reames ◽  
Timothy M. Pawlik ◽  
Aslam Ejaz ◽  
Hugo Marques ◽  
Luca Aldrighetti ◽  
...  

275 Background: Major vascular (IVC or portal vein) resection for Intrahepatic Cholangiocarcinoma (ICC) has traditionally been considered a relative contraindication to resection. We sought to define perioperative outcomes and survival of ICC patients undergoing liver surgery with major vascular resection using a multi-institutional database. Methods: 1,087 ICC patients who underwent liver resection between 1990-2016 were identified from 13 participating institutions. Multivariable logistic and cox regressions were used to determine the impact of major vascular resection on perioperative outcomes and long-term overall survival. Results: Of 1,087 patients who underwent resection, 128(11.8%) also underwent major vascular resection [21(16.4%)IVC resections, 98(76.6%)PV resections, 9(7.0%)combined resections]. One hundred eighty-seven(17.2%) patients received neoadjuvant therapy. Most patients underwent a major hepatectomy involving ≥ 3 liver segments(n = 664,61.1%). On final pathology, the majority of patients had T1(40.4%) or T2(35.5%) tumors; 194(17.8%) had lymph node metastasis. Patients undergoing major vascular resection had more advanced T3/T4 tumors [44(34.4%) vs. 137(14.3%) without resection;P < 0.001]. Of note, major vascular resection was not associated with the risk of any complication (OR .680,95%CI 0.32-1.45) or major complication (OR 0.69,95%CI 0.35-1.33); post-operative mortality was also comparable between groups (OR 1.06, 95%CI 0.32-3.48). In addition, median recurrence-free (14.0 months vs.14.7 months, HR.737,95%CI .49-1.10) and overall (33.4 months vs.40.2 months, HR .709,95%CI.36-1.40) survival were similar among patients who did and did not undergo major vascular resection, respectively(both P > 0.05). Conclusions: Among patients with ICC, major vascular resection was not associated with increased peri-operative morbidity or mortality at major centers. Long-term outcomes following resection of ICC requiring vascular resection were also comparable to outcomes following resection of tumors without vascular involvement. Concurrent major vascular resection should be considered in appropriately selected ICC patients.


Sign in / Sign up

Export Citation Format

Share Document